Watch the video or read the poster to learn about:
The benefits of using stable cell lines to produce lentivirus
The advantages the EuLV lentiviral production system offers as compared to plasmid transfection
An example 25L-scale LVV production process in WAVE Bioreactor
Mr Liu graduated from the Hong Kong University of Science and Technology with a Master degree in Biotechnology. He previously worked in Bio-techne and InvivoGen. Mr Liu joined Eureka Bio in 2016 as COO, and he has extensive knowledge in Gene and Cell therapy industry, and is experienced in business development, project management, process development, cGMP etc.